Covington & Burling

International Top 30 position: 25

Judgment of the EU Court of Justice in AstraZeneca v Commission

On 6 December 2012, the EU Court of Justice dismissed AstraZeneca’s appeal of the General Court’s judgment in AstraZeneca v Commission. The Court of Justice affirmed the reasoning and holdings of the General Court and rejected all of AstraZeneca’s arguments, including its challenge to the General Court’s analysis of the definition of the relevant markets and the findings that AstraZeneca’s IP and regulatory strategies related to its product Losec constituted an abuse of a dominant position in violation of Article 102 TFEU. This judgment, from the EU’s highest court, solidifies the concept of an abuse of IP and regulatory procedures, and thus will come as a disappointment to many life science companies.

Click on the link above to download this Covington & Burling briefing.

Briefings from Covington & Burling

View more briefings from Covington & Burling

Analysis from The Lawyer

  • Bale

    Summer Round-up: Deals, booted

    Footie and telecoms dominate our regular round-up of recent M&A activity, as the threat of rising interest rates kick-started activity among organisations.

Browse This Firm’s


265 Strand

Firmwide revenue 2011 ($m): 611
Global lawyers 2011: 781